Codiak BioSciences, Inc. Operating Lease, Payments
Codiak BioSciences, Inc. reported Operating Lease, Payments of $4.70 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2022-11-03
- Codiak BioSciences, Inc. operating lease, payments for the quarter ending 2022-09-30 was $1.60M, a 6.67% increase year-over-year.
- Codiak BioSciences, Inc. operating lease, payments for the quarter ending 2022-06-30 was $1.54M, a 1.65% increase year-over-year.
- Codiak BioSciences, Inc. operating lease, payments for the quarter ending 2022-03-31 was $1.56M, a 5.06% increase year-over-year.
- Codiak BioSciences, Inc. operating lease, payments for the quarter ending 2021-12-31 was $1.50M, a 7.14% increase year-over-year.
- Codiak BioSciences, Inc. operating lease, payments for fiscal 2021 was $6.00M, a 0.00% change from fiscal 2020.
- Codiak BioSciences, Inc. operating lease, payments for fiscal 2020 was $6.00M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2022-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $3.14M derived: sum of 2 quarters · filed 2022-11-03 | $4.70M 10-Q · filed 2022-11-03 | $6.20M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | $1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $3.10M 10-Q · filed 2022-08-04 | $4.60M derived: sum of 3 quarters · filed 2022-08-04 | $6.10M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-03-31 | $1.56M 10-Q · filed 2022-05-05 | $3.06M derived: sum of 2 quarters · filed 2022-05-05 | $4.56M derived: sum of 3 quarters · filed 2022-11-03 | $6.08M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $3.00M derived: sum of 2 quarters · filed 2022-11-03 | $4.52M derived: sum of 3 quarters · filed 2022-11-03 | $6.00M 10-K · filed 2022-03-10 |
| 2021-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $3.02M derived: sum of 2 quarters · filed 2022-11-03 | $4.50M 10-Q · filed 2022-11-03 | $5.90M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $3.00M 10-Q · filed 2022-08-04 | $4.40M derived: sum of 3 quarters · filed 2022-08-04 | $5.90M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $1.48M 10-Q · filed 2022-05-05 | $2.88M derived: sum of 2 quarters · filed 2022-05-05 | $4.38M derived: sum of 3 quarters · filed 2022-05-05 | $5.79M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $2.90M derived: sum of 2 quarters · filed 2022-03-10 | $4.30M derived: sum of 3 quarters · filed 2022-03-10 | $6.00M 10-K · filed 2022-03-10 |
| 2020-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $2.90M derived: sum of 2 quarters · filed 2021-11-04 | $4.60M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $3.10M 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $1.70M 10-Q · filed 2021-05-06 |